Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for the Class 2 Modified New Drug - Amhydrocodone Paracetamol Extended-Release Tablets

About this update from Chengdu Easton Biopharmaceuticals Co., Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for the Class 2 Modified New Drug - Amhydrocodone Paracetamol Extended-Release Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chengdu Easton Biopharmaceuticals Co., Ltd. Class A